AngioDynamics (ANGO) at a 52-Week High: What’s Driving It?
Shares of AngioDynamics Inc. ANGO reached a new 52-week high of $22.71 on Mar 9, before closing the session marginally lower at $ 21.77. The stock has rallied 34.5% since its second-quarter earnings announcement on more...
Naturally Splendid to Ship 20 Tonnes of Hemp to South Korea
VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSX-V:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce the Company has received another Purchase Order from its roster of clients in more...
Harvest One Completes Sale of Satipharm for Approximately $4 Million
Vancouver, British Columbia–(Newsfile Corp. – March 10, 2021) – Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF), a uniquely positioned cannabis-infused CPG leader, is pleased to announce today, further to its news release dated February more...
THC BioMed ships THC Kiss Gummies to the Province of B.C. and Launches New E-Commerce Platform
THC BioMed ships THC Kiss Gummies to the Province of B.C. and Launches New E-Commerce Platform PR Newswire THC.CSE THCBF – OTC TFHD.F VANCOUVER, BC, March 10, 2021 /PRNewswire/ – THC BioMed Intl Ltd. (” THC BioMed ” or the ” Company more...
Chiasma to Present New Data from Two Phase 3 Trials, CHIASMA OPTIMAL and MPOWERED(TM), at ENDO 2021
— One oral presentation and five late-breaking posters accepted — NEEDHAM, Mass., March 10, 2021 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology more...
Eyenovia to Participate in the 33rd Annual Roth Conference
NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, more...
Leading Cancer Researcher Dr. Judith Varner Joins aTyr Pharma as Scientific Advisor
Dr. Varner to advise company on mechanistic understanding of Neuropilin-2 (NRP2) and the development of novel anti-NRP2 antibody therapeutics for cancer SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a more...
Daré Bioscience to Participate in Upcoming Virtual Conferences
SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Executive Officer, will participate in the following more...
Cocrystal Pharma Extends Drug Discovery Collaboration with HitGen and InterX
BOTHELL, Wash, March 10, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, more...
XOMA Reports Fourth Quarter and Full-Year 2020 Financial Results and Operating Highlights
Recognized revenue of $29.4 million Six assets in the Company’s milestone and royalty portfolio advanced to Phase 2 clinical development Completed $24.6 million Series A Perpetual Preferred Stock offering paying a 8.625% dividend Ended 2020 more...